Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized,...
9
Transcript of Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized,...
![Page 1: Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized, double-blind—phase 2 study of ruxolitinib or placebo in combination with capecitabine in subjects](https://reader035.fdocuments.net/reader035/viewer/2022071410/6104c7b3c4f42e5c450107b5/html5/thumbnails/1.jpg)
![Page 2: Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized, double-blind—phase 2 study of ruxolitinib or placebo in combination with capecitabine in subjects](https://reader035.fdocuments.net/reader035/viewer/2022071410/6104c7b3c4f42e5c450107b5/html5/thumbnails/2.jpg)
![Page 3: Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized, double-blind—phase 2 study of ruxolitinib or placebo in combination with capecitabine in subjects](https://reader035.fdocuments.net/reader035/viewer/2022071410/6104c7b3c4f42e5c450107b5/html5/thumbnails/3.jpg)
![Page 4: Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized, double-blind—phase 2 study of ruxolitinib or placebo in combination with capecitabine in subjects](https://reader035.fdocuments.net/reader035/viewer/2022071410/6104c7b3c4f42e5c450107b5/html5/thumbnails/4.jpg)
![Page 5: Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized, double-blind—phase 2 study of ruxolitinib or placebo in combination with capecitabine in subjects](https://reader035.fdocuments.net/reader035/viewer/2022071410/6104c7b3c4f42e5c450107b5/html5/thumbnails/5.jpg)
![Page 6: Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized, double-blind—phase 2 study of ruxolitinib or placebo in combination with capecitabine in subjects](https://reader035.fdocuments.net/reader035/viewer/2022071410/6104c7b3c4f42e5c450107b5/html5/thumbnails/6.jpg)
![Page 7: Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized, double-blind—phase 2 study of ruxolitinib or placebo in combination with capecitabine in subjects](https://reader035.fdocuments.net/reader035/viewer/2022071410/6104c7b3c4f42e5c450107b5/html5/thumbnails/7.jpg)
![Page 8: Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized, double-blind—phase 2 study of ruxolitinib or placebo in combination with capecitabine in subjects](https://reader035.fdocuments.net/reader035/viewer/2022071410/6104c7b3c4f42e5c450107b5/html5/thumbnails/8.jpg)
![Page 9: Neuroendocrine Tumors Napoli · 2017. 1. 25. · Trial INC 18424-268— "A randomized, double-blind—phase 2 study of ruxolitinib or placebo in combination with capecitabine in subjects](https://reader035.fdocuments.net/reader035/viewer/2022071410/6104c7b3c4f42e5c450107b5/html5/thumbnails/9.jpg)